Literature DB >> 18285484

In vivo therapeutic effect of gatifloxacin on BALB/c mice infected with Nocardia brasiliensis.

Alejandra Daw-Garza1, Oliverio Welsh, Salvador Said-Fernández, Hector Gerardo Lozano-Garza, Noemi Waksman de Torres, Norma Cavazos Rocha, Jorge Ocampo-Candiani, Lucio Vera-Cabrera.   

Abstract

In the present work, we evaluated the effect of gatifloxacin on the evolution of experimental murine infection with Nocardia brasiliensis using linezolid as a control. Gatifloxacin was injected subcutaneously at 100 mg/kg body weight every 8 h for 4 weeks. This compound was equally as efficient as linezolid in reducing the production of lesions.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18285484      PMCID： PMC2292517          DOI： 10.1128/AAC.00148-08

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  8 in total

1.  Two cases of Nocardia asteroides sternotomy infection treated with ofloxacin and a review of other active antimicrobial agents.

Authors:  W W Yew; P C Wong; S Y Kwan; C Y Chan; M S Li
Journal:  J Infect       Date:  1991-11       Impact factor: 6.072

2.  Treatment of pulmonary nocardiosis in heart-transplant patients: importance of susceptibility studies.

Authors:  M F Tripodi; L E Adinolfi; A Andreana; G Sarnataro; E Durante Mangoni; M Gambardella; R Casillo; C Farina; R Utili
Journal:  Clin Transplant       Date:  2001-12       Impact factor: 2.863

Review 3.  Mycetoma.

Authors:  Oliverio Welsh; Lucio Vera-Cabrera; Mario Cesar Salinas-Carmona
Journal:  Clin Dermatol       Date:  2007 Mar-Apr       Impact factor: 3.541

4.  Clinical experience with linezolid for the treatment of nocardia infection.

Authors:  Edina H Moylett; Susan E Pacheco; Barbara A Brown-Elliott; Tracy R Perry; E Stephen Buescher; Mary C Birmingham; Jerome J Schentag; Joseph F Gimbel; Aaron Apodaca; Margot A Schwartz; Robert M Rakita; Richard J Wallace
Journal:  Clin Infect Dis       Date:  2003-01-13       Impact factor: 9.079

5.  Simultaneous determination and validation of antimicrobials in plasma and tissue of actinomycetoma by high-performance liquid chromatography with diode array and fluorescence detection.

Authors:  Norma Cavazos-Rocha; Lucio Vera-Cabrera; Oliverio Welsh-Lozano; Noemí Waksman-de-Torres; María de la Luz Salazar-Cavazos
Journal:  J Pharm Biomed Anal       Date:  2007-01-05       Impact factor: 3.935

6.  [Epidemiology of mycetoma in Mexico: study of 2105 cases].

Authors:  R López Martínez; L J Méndez Tovar; P Lavalle; O Welsh; A Saúl; E Macotela Ruíz
Journal:  Gac Med Mex       Date:  1992 Jul-Aug       Impact factor: 0.302

7.  In vitro activities of new antimicrobials against Nocardia brasiliensis.

Authors:  Lucio Vera-Cabrera; Eva Gonzalez; Sung H Choi; Oliverio Welsh
Journal:  Antimicrob Agents Chemother       Date:  2004-02       Impact factor: 5.191

8.  In vitro and in vivo activities of antimicrobials against Nocardia brasiliensis.

Authors:  Alejandra Gomez-Flores; Oliverio Welsh; Salvador Said-Fernández; Gerardo Lozano-Garza; Roman Erick Tavarez-Alejandro; Lucio Vera-Cabrera
Journal:  Antimicrob Agents Chemother       Date:  2004-03       Impact factor: 5.191
  8 in total
  3 in total

1.  In vitro activity of ACH-702, a new isothiazoloquinolone, against Nocardia brasiliensis compared with econazole and the carbapenems imipenem and meropenem alone or in combination with clavulanic acid.

Authors:  Lucio Vera-Cabrera; Mayra Paola Campos-Rivera; Wendy G Escalante-Fuentes; Michael J Pucci; Jorge Ocampo-Candiani; Oliverio Welsh
Journal:  Antimicrob Agents Chemother       Date:  2010-03-22       Impact factor: 5.191

2.  Efficacy of ciprofloxacin and moxifloxacin against Nocardia brasiliensis in vitro and in an experimental model of actinomycetoma in BALB/c mice.

Authors:  Brenda Edith Chacon-Moreno; Oliverio Welsh; Norma Cavazos-Rocha; Maria de la Luz Salazar-Cavazos; Hector Gerardo Garza-Lozano; Salvador Said-Fernandez; Jorge Ocampo-Candiani; Lucio Vera-Cabrera
Journal:  Antimicrob Agents Chemother       Date:  2008-10-13       Impact factor: 5.191

3.  Therapeutic effect of a novel oxazolidinone, DA-7867, in BALB/c mice infected with Nocardia brasiliensis.

Authors:  Lucio Vera-Cabrera; Alejandra Daw-Garza; Salvador Said-Fernández; Hector Gerardo Lozano-Garza; Noemi Waksman de Torres; Norma Cavazos Rocha; Jorge Ocampo-Candiani; Sung-Hak Choi; Oliverio Welsh
Journal:  PLoS Negl Trop Dis       Date:  2008-09-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.